Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NACC2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | AADACL2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | RP11-463D19.2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | MMS22L | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | MSH2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | AKAP8 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | FAM180A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | ANKRD6 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | KIZ | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |